| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast
|
Allnutt, F.C. Thomas
|
|
2007
|
25 |
26 |
p. 4880-4888
9 p.
|
artikel
|
| 2 |
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
|
Gruener, Norbert H.
|
|
2007
|
25 |
26 |
p. 4960-4966
7 p.
|
artikel
|
| 3 |
Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques
|
Chong, Siew-Yen
|
|
2007
|
25 |
26 |
p. 4967-4982
16 p.
|
artikel
|
| 4 |
Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines
|
Wan, Yanmin
|
|
2007
|
25 |
26 |
p. 4949-4959
11 p.
|
artikel
|
| 5 |
Do immunisations reduce the risk for SIDS? A meta-analysis
|
Vennemann, M.M.T.
|
|
2007
|
25 |
26 |
p. 4875-4879
5 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2007
|
25 |
26 |
p. CO2-
1 p.
|
artikel
|
| 7 |
Effect of the purification process and the storage conditions on the efficacy of an inactivated vaccine against heartwater
|
Marcelino, Isabel
|
|
2007
|
25 |
26 |
p. 4903-4913
11 p.
|
artikel
|
| 8 |
Ethical considerations related to the provision of care and treatment in vaccine trials
|
Tarantola, D.
|
|
2007
|
25 |
26 |
p. 4863-4874
12 p.
|
artikel
|
| 9 |
Immunization of mice with DNA coding for the variable regions of anti-idiotypic antibody generates antigen-specific response
|
Vani, J.
|
|
2007
|
25 |
26 |
p. 4922-4930
9 p.
|
artikel
|
| 10 |
Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants
|
Esposito, Susanna
|
|
2007
|
25 |
26 |
p. 4889-4894
6 p.
|
artikel
|
| 11 |
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
|
Olsson, Sven-Eric
|
|
2007
|
25 |
26 |
p. 4931-4939
9 p.
|
artikel
|
| 12 |
Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey
|
Theeten, Heidi
|
|
2007
|
25 |
26 |
p. 4940-4948
9 p.
|
artikel
|
| 13 |
Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses
|
Nagata, Tomoya
|
|
2007
|
25 |
26 |
p. 4914-4921
8 p.
|
artikel
|
| 14 |
Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine
|
D’Ugo, Emilio
|
|
2007
|
25 |
26 |
p. 4895-4902
8 p.
|
artikel
|
Tijdschrift beschrijving